CUE Cue Biopharma Inc.

Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.

$10.97  -0.40 (-3.52%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2018
Outstanding shares:  31,760,946
Average volume:  413,180
Market cap:   $361,121,956
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    22978P106
ISIN:        US22978P1066
Sedol:      BD9G8M7
Valuation   (See tab for details)
PE ratio:   -7.43
PB ratio:   5.42
PS ratio:   50.42
Return on equity:   -73.80%
Net income %:   -654.53%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy